Delos Reyes, Sarah Mae .
HRN: 27-29-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/08/2025
06/15/2025
IV
4.5g LD Then 2.25g
Q8h
CAP HR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: